Norwegian biotech developing diagnostic tools for conditions in the painful joint.
Proprietary, CE/IVD, rapid and patient near test for early stage detection and stratification of infection and aseptic loosing in artificial, replaced joints, based on analysis of a joint fluid biopsy.
Test will increase diagnostic accuracy, improve outcome for the patient, and reduce cost Test; answers the surgeon’s two major diagnostic needs in 15 minutes.